LIVN logo

LIVN LivaNova PLC

NASDAQ Global Select · Medical - Devices · Healthcare

$90.73
-1.34 (-1.46%)

LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS The…

Market Cap: $5.00Bwww.livanova.com

Price

No data yet.

Social Signal Score

70
5d
—
30d
72
5 mentions
—
60d
72
5 mentions
—
90d
65
6 mentions
—
news: 6

Analyst Ratings

15 analysts
Buyconsensus
Strong Buy 0Buy 12Hold 2Sell 1Strong Sell 0
Avg price target$100+10.2%
Low $85Median $93High $120
Current Consensus

Revenue

$393.10M+26.56%
$182.21M$252.50M$322.80M$393.10M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$3.86
$3.85–$3.87
6 analysts
FY2026
$4.44+15% YoY
$4.39–$4.47
7 analysts
FY2027
$4.73+6% YoY
$4.58–$4.83
6 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Vladimir A. Makatsaria
Sector
Healthcare
Industry
Medical - Devices
Employees
3,300
Beta
0.92
Country
GB
Piotroski score
7 / 9 (Strong)
Altman Z-score
3.14
www.livanova.com